MEDICINAL SCIENCES
These lines cover core scientific disciplines enabling delivery of medicines and vaccines from idea to loss of exclusivity and include industry-leading capabilities with more than 2,700 colleagues in ten major sites working on every project within Pfizer’s portfolio
Improved or next generation bioprocess, analytical, formulation and delivery technologies for biopharmaceuticals, vaccines and gene therapies
Transformational technologies to design, construct, and optimize biotherapeutics
Multi-discipline small molecule group encompassing medicinal chemistry, drug metabolism, structural biology, phenotypic screening, target-based screening, functional genomics, computational chemistry, biology, and translational modeling and simulation
Computational Product and Process Design
